Skip to main content
. 2021 Dec 22;2021:7849032. doi: 10.1155/2021/7849032

Table 2.

The first 20 key targets of LGZG decoction in treating hyperlipidemias.

No. Target name Betweenness centrality Closeness centrality Degree
1 TNF 0.1205 0.7204 41
2 AKT1 0.1198 0.7053 40
3 PPARG 0.1057 0.6907 38
4 PPARA 0.0951 0.6569 33
5 IL1B 0.0514 0.6505 32
6 PTGS2 0.0414 0.6091 28
7 RXRA 0.0320 0.6036 24
8 EGFR 0.0230 0.5877 24
9 ACE 0.0371 0.5982 23
10 HMGCR 0.0370 0.5776 20
11 NR3C1 0.0147 0.5492 20
12 ABCA1 0.0240 0.5678 19
13 AGT 0.0320 0.5678 19
14 NR1H3 0.0090 0.5630 18
15 IFNG 0.0144 0.5678 18
16 ESR1 0.0104 0.5194 18
17 REN 0.0139 0.5537 17
18 IL4 0.0105 0.5583 17
19 CETP 0.0142 0.5194 16
20 RXRB 0.0072 0.5276 16